Fascin expression in invasive ductal carcinoma of breast

Turk Patoloji Dergisi/Turkish Journal of Pathology

Volumn 26, Issue 2, 2010, Pages 130-135

  Erdoǧan, Gülgün ^a   Peştereli, H Elif ^a   Çolak, Taner ^a   Karaveli, F Şeyda ^a   Akaydin, Mustafa ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Breast carcinomas; Fascin; Metastatic potential

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FASCIN; FASCIN ANTIBODY; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MASTECTOMY; PHENOTYPE; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 77952911628     PISSN: 10185615     EISSN: 13095730     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hashimoto Y, Skacel M, Adams JC: Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J of Biochemistry & Cell Biology 2005, 37(9): 1787-1804
2. Carr KM, Rosenblatt K, Petricoin EF, Liotta LA: Genomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy. Hum Genomics 2004, 1: 134-140
3. Buda A, Pignatelli M: Cytoskeletal network in colon cancer: from genes to clinical application. Int J Biochem Cell Biol 2004, 36: 759-765 (Pubitemid 38299390)
4. Guo W, Giancotti FG: Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004, 5:816-826
5. Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Bröcker EB, Friedl P: Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 2003, 160: 267-277 (Pubitemid 36254960)
6. Guvakova MA, Boettiger D, Adams JC: Induction of fascin spikes in breast cancer cells by activation of the insulin-like growth factor-I receptor. Int J of Biochem Cell Biol 2002, 34(9): 685-698 (Pubitemid 34270721)
7. Carragher NO, Frame MC: Focal adhesion and actin dynamics: a place where kinases and proteases meet to promote invasion. Trends in Cell Biol 2004, 14: 241-244
8. Pelosi G, Pastorino U, Pasini F, Maissoneuve P, Fraggetta F, Iannucci A, Sonzogni A, De Manzoni G, Terzi A, Durante E, Bresaola E, Pezzella F, Viale G: Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. B J Cancer 2003, 88: 538-547 (Pubitemid 36363363)
9. Kureishy N, Sapountzi V, Prag S, Anilkumar N, Adams JC: Fascins, and their roles in cell structure and function. Bioessays 2002, 24: 350-361 (Pubitemid 34305690)
10. Adams JC: Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol 2004, 16(5): 590-596
11. Tsai WC, Sheu LF, Nieh S, Yu CP, Sun GH, Lin YF, Chen A, Jin JS: Association of eMMPRIN and fascin expression in renal cell carcinoma: correlation with clinicopathological parameters. World J Urol 2007, 25(1): 73-80
12. Yoder BJ, Tso E, Skacel M, Pettay J, Tarr S, Budd T, Tubbs RR, Adams JC, Hicks DG: The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin Cancer Res 2005, 11(1):186-192 (Pubitemid 40075794)
13. Zhang FR, Tao LH, Shen ZY, Lv Z, Xu LY, Li EM: Fascin expression in human embryonic, fetal, and normal adult tissue. J Histochem Cytochem 2008, 56(2): 193-199 (Pubitemid 351170971)
14. Choi PJ, Yang DK, Son CH, Lee KE, Lee JI, Roh MS: Fascin immunoreactivity for preoperatively predicting lymph node metastases in peripheral adenocarcinoma of the lung 3 cm or less in diameter. eur J Cardiothorac Surg 2006, 30(3): 538-542
15. Gunal A, Onguru O, Safali M, Beyzadeoglu M: Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas. Neuropathology 2008; Feb 18 [epub ahead of print]
16. Tsai WC, Chao YC, Sheu LF, Lin YF, Nieh S, Chen A, Yu CP, Jin JS: EMMPRIN and fascin overexpression associated with clinicopathologic parameters of pancreatobiliary adenocarcinoma in Chinese people. APMIS 2007, 115(8):929-938 (Pubitemid 47256286)
17. Chen SF, Yang SF, Li JW, Nieh PC, Lin SY, Fu E, Bai CY, Jin JS, Lin CY, Nieh S: expression of fascin in oral and oropharyngeal squamous cell carcinomas has prognostic significance - a tissue microarray study of 129 cases. Histopathology 2007, 51(2):173-183 (Pubitemid 47083998)
18. Vignjevic D, Schoumacher M, Gavert N, Janssen KP, Jih G, Laé M, Louvard D, Ben-Ze'ev A, Robine S: Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res 2007, 67(14): 6844-6853 (Pubitemid 47105531)
19. Lee TK, Poon RT, Man K, Guan XY, Ma S, Liu XB, Myers JN, Yuen AP: Fascin over-expression is associated with aggressiveness of oral squamous cell carcinoma. Cancer Lett 2007, 254(2):308-315 (Pubitemid 47135617)
20. Tsai WC, Chao YC, Sheu LF, Chang JL, Nieh S, Jin JS: Overexpression of fascin-1 in advanced colorectal adenocarcinoma: tissue microarray analysis of immunostaining scores with clinicopathological parameters. Dis Markers 2007, 23(3):153-160 (Pubitemid 46868405)
21. Okada K, Shimura T, Asakawa K, Hashimoto S, Mochida Y, Suehiro T, Kuwano H: Fascin expression is correlated with tumor progression of extrahepatic bile duct cancer. Hepatogastroenterology. 2007, 54(73):17-21 (Pubitemid 46511638)
22. Yamaguchi H, Inoue T, Eguchi T, Miyasaka Y, Ohuchida K, Mizumoto K, Yamada T, Yamaguchi K, Tanaka M, Tsuneyoshi M: Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade. Mod Pathol 2007, 20(5): 552-561
23. Puppa G, Maisonneuve P, Sonzogni A, Masullo M, Chiappa A, Valerio M, Zampino MG, Franceschetti I, Capelli P, Chilosi M, Menestrina F, Viale G, Pelosi G: Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma. Br J Cancer 2007, 96 (7):1118-1126
24. Xue LY, Hu N, Song YM, Zou SM, Shou JZ, Qian LX, Ren LQ, Lin DM, Tong T, He ZG, Zhan QM, Taylor PR, Lu N: Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma. BMC Cancer 2006, 6:296
25. Hashimoto Y, Skacel M, Lavery IC, Mukherjee AL, Casey G, Adams JC: Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas. BMC Cancer 2006, 6:241
26. Jin JS, Yu CP, Sun GH, Lin YF, Chiang H, Chao TK, Tsai WC, Sheu LF: Increasing expression of fascin in renal cell carcinoma associated with clinicopathological parameters of aggressiveness. Histol Histopathol 2006, 21: 1287-1293
27. Jawhari AU, Buda A, Jenkins M, Shehzad K, Sarraf C, Noda M, Farthing MJ, Pignatelli M, Adams JC: Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol 2003, 162: 69-80
28. Bakshi NA, Finn WG, Schnitzer B, Valdez R, Ross CW: Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma. Arch Pathol Lab Med 2007, 131: 742-747
29. Haagensen CD: Diseases of the Breast. 3rd ed. Philadelphia, WB Saunders, 1986, 173
30. Hashimoto Y, Shimada Y, Kawamura J, Yamasaki S, Imamura M: The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 2004, 67: 262-270 (Pubitemid 39551711)
31. Zhang H, Xu L, Xiao D, Xie J, Zeng H, Cai W, Niu Y, Yang Z, Shen Z, Li E: Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma. J Clin Pathol 2006, 59: 958-964
32. Hu W, McCrea PD, Deavers M, Kavanagh JJ, Kudelka AP, Verschraegen CF: Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors. Clin exp Metastasis 2000, 18(1): 83-88
33. Grothey A, Hashizume R, Sahin AA, McCrea PD: Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br J Cancer. 2000 83, 42:1870-1873
34. Grothey A, Hashizume R, Ji H, Tubb BE, Patrick CW Jr, Yu D, Mooney EE, McCrea PD: C-erbB-2/HeR-2 upregulates fascin, an actin-bundling associated with cell motility, in human breast cancer cell lines. Oncogene 2000, 19: 4864-4875